Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.

How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market

Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led by established 1st generation tyrosine kinase inhibitors (TKIs). There were several scenarios that the client wanted to test, including impact of launch order and the impact of future 3rd generation TKIs on the drug’s market potential. The research was complicated by the fact that both the clients (and likely key future competitors’), profile was as yet unknown – the research therefore needed to assess likely share while taking account of multiple moving parts.

read more »

  • Posted by Marc Yates
  • February 16, 2018
  • News

Research conducted by Research Partnership published in leading medical journal

Research conducted by Research Partnership published in leading medical journal

Findings from a study conducted by Research Partnership have recently been published in the ‘Supportive Care in Cancer’ journal

Commissioned by Mundipharma, the paper is titled ‘Patient and oncologist perceptions regarding symptoms and impact on quality-of-life of oral mucositis in cancer treatment: results from the Awareness Drives Oral Mucositis PercepTion (ADOPT) study’. The aim of the research was to assess the level of concordance between the perspectives of oncologists and those of patients regarding oral mucositis (OM) symptoms, and the impact of OM on various aspects of daily living and concurrent cancer management. 
 
 

read more »

Prostate Cancer Market Snapshot infographic

Prostate Cancer Market Snapshot infographic

An overview of the prostate cancer patient

Download our Therapy Watch PCa market snapshot which provides you with an overview of the prostate cancer patient and the therapy regimens followed by the different patient segments.

read more »

  • Posted by Allison Fleetwood
  • June 23, 2014
  • News

Monitor the evolving Prostate Cancer landscape with Therapy Watch PCa

Monitor the evolving Prostate Cancer landscape with Therapy Watch PCa

With second generation hormonal agents now beginning to be used in earlier stages of treatment, pharma market researchers require in-depth insights into the PCa market in order to measure the impact of new treatments as they launch.

With second generation hormonal agents now beginning to be used in earlier stages of treatment, pharma market researchers require in-depth insights into the PCa market in order to measure the impact of new treatments as they launch.
Available to purchase now, Therapy Watch PCa provides real-time insights into key patient segments, hormonal treatment paradigms and treatment drivers, enabling you to identify key insights ahead of the competition and drive your marketing strategy.

read more »